|
DHX36 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.76185999999356E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.19199999995645E-06 |
| Normal-vs-Stage2 |
3.082000E-02 |
| Normal-vs-Stage3 |
7.683700E-02 |
| Normal-vs-Stage4 |
1.590560E-04 |
| Stage1-vs-Stage2 |
6.382400E-01 |
| Stage1-vs-Stage3 |
2.740000E-01 |
| Stage1-vs-Stage4 |
5.535400E-01 |
| Stage2-vs-Stage3 |
6.912400E-01 |
| Stage2-vs-Stage4 |
3.647200E-01 |
| Stage3-vs-Stage4 |
2.430200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.02609999999659E-05 |
| Normal-vs-AfricanAmerican |
7.6485000000015E-05 |
| Normal-vs-Asian |
2.144800E-01 |
| Caucasian-vs-AfricanAmerican |
6.316000E-01 |
| Caucasian-vs-Asian |
9.677200E-01 |
| AfricanAmerican-vs-Asian |
8.900200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.09030000028376E-07 |
| Normal-vs-Female |
3.844600E-01 |
| Male-vs-Female |
7.6846999999991E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.684600E-03 |
| Normal-vs-Extreme_Weight |
3.95189999946588E-07 |
| Normal-vs-Obese |
2.398600E-04 |
| Normal-vs-Extreme_Obese |
5.475700E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.880000E-01 |
| Normal_Weight-vs-Obese |
9.828800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.157800E-01 |
| Extreme_Weight-vs-Obese |
1.996020E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.776800E-01 |
| Obese-vs-Extreme_Obese |
5.282200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.836200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.996600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.34389999995044E-06 |
| Normal-vs-Age(81-100Yrs) |
1.6829000000218E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.331450E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.390400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.544900E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.165800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.073600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.554600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.51499999995397E-06 |
| Normal-VS-Type2 PRCC |
7.93250000000745E-05 |
| Normal-VS-KIRP CIMP |
6.101200E-01 |
| Normal-VS-Unclassified PRCC |
6.571600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.361200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.789570E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.320400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.118100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.005800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.572770E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.82570000228921E-08 |
| Normal-vs-N1 |
8.355200E-01 |
| Normal-vs-N2 |
2.195200E-03 |
| N0-vs-N1 |
4.279400E-03 |
| N0-vs-N2 |
7.641800E-01 |
| N1-vs-N2 |
1.447830E-01 |
|
|
